1-13 of 13
quality-adjusted life years
Close
Sort by
Journal Articles

Is It Time to Take MRD More Seriously? Relationship between MRD, Functional Cure and Life Expectancy Among Patients with Ph- B Cell Precursor ALL (BCP-ALL)

Qiujun Shao, Simran Tiwana, Nicholas Despiegel, Franziska Dirnberger
Journal: Blood
Blood (2019) 134 (Supplement_1): 5814.
https://doi.org/10.1182/blood-2019-126309
Published: 2019
Journal Articles

The Economic Value of CTL019 Therapy for Pediatric Patients with Relapsed and Refractory Acute Lymphoblastic Leukemia in the United Kingdom

Julia Snider, PhD, Michelle Brauer, BS, Yanni Hao, PhD, Pinar Karaca-Mandic, PhD, Mahlet Gizaw Tebeka, MS, Jie Zhang, PhD, Katharine Batt, MD MSc
Journal: Blood
Blood (2017) 130 (Supplement 1): 1330.
https://doi.org/10.1182/blood.V130.Suppl_1.1330.1330
Published: 2017
Journal Articles

Cost-Effectiveness Analysis of CTL019 for the Treatment of Pediatric and Young Adult Patients with Relapsed or Refractory B-Cell Acute Lymphoblastic Leukemia in the United States

Yanni Hao, PhD, Lamis K. Eldjerou, MD, Hongbo Yang, PhD, Cynthia Qi, MBA, Denise Globe, PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 609.
https://doi.org/10.1182/blood.V130.Suppl_1.609.609
Published: 2017
Journal Articles

Health Utility during the First Two Years of Treatment of Hematological Malignancies

Sonya Cressman, PhD, Mary Lynn Savoie, MD FRCPC, Stephen Couban, MD, Emily McPherson, Alexa Evans, Stuart Peacock
Journal: Blood
Blood (2016) 128 (22): 3608.
https://doi.org/10.1182/blood.V128.22.3608.3608
Published: 2016
Journal Articles

Economic Evaluation of Carfilzomib+Dexamethasone (Kd) Vs Bortezomib+Dexamethasone (Vd) in Relapsed or Refractory Multiple Myeloma (R/RMM)

Andrzej Jakubowiak, MD PhD, Istvan Matyas Majer, PhD, Ivan Houisse, MSc, Agnes Benedict, Marco Campioni, Sumeet Panjabi, Sikander Ailawadhi, MD
Journal: Blood
Blood (2016) 128 (22): 3582.
https://doi.org/10.1182/blood.V128.22.3582.3582
Published: 2016
Journal Articles

Value of innovation in hematologic malignancies: a systematic review of published cost-effectiveness analyses

Clinical Trials & Observations
Cayla J. Saret, Aaron N. Winn, Gunjan Shah, Susan K. Parsons, Pei-Jung Lin, Joshua T. Cohen, Peter J. Neumann
Journal: Blood
Blood (2015) 125 (12): 1866–1869.
https://doi.org/10.1182/blood-2014-07-592832
Published: 2015
Includes: Supplemental data
Journal Articles

A Cost-Utility and Budget Impact Analysis of Allogeneic Hematopoietic Stem Cell Transplantation for Severe Thalassemic Patients In Thailand.

Suradej Hongeng, Samart Pakakasama, Nongnuch Sirachainan, MD, Ampaiwan Chuansumrit
Journal: Blood
Blood (2010) 116 (21): 1536.
https://doi.org/10.1182/blood.V116.21.1536.1536
Published: 2010
Journal Articles

A Disease Model to Predict the Long-Term Outcomes Associated with Treatments for Chronic Myelogenous Leukemia (CML).

Matthew Taylor, PhD, Lily Lewis, BSc, Thomas Patton, MSc, Ishan Hirji, BSP(Pharm), MPH, Catherine Davis, PharmD
Journal: Blood
Blood (2010) 116 (21): 4480.
https://doi.org/10.1182/blood.V116.21.4480.4480
Published: 2010
Journal Articles

Choosing First-Line Therapy for Follicular Lymphoma (FL): A Decision Analysis

Rebecca L. Olin, MD, Peter A. Kanetsky, PhD, MPH, Thomas Ten Have, PhD, MPH, Sunita Dwivedy Nasta, MD, Stephen J. Schuster, MD, Charalambos Andreadis, MD, MSCE
Journal: Blood
Blood (2008) 112 (11): 670.
https://doi.org/10.1182/blood.V112.11.670.670
Published: 2008
Journal Articles

A Cost-Effectiveness Analysis of Coagulation Testing Prior to Tonsillectomy and Adenoidectomy in Children.

James D. Cooper, MD, Kenneth J Smith, MD, MS, Arthur Kim Ritchey, MD
Journal: Blood
Blood (2008) 112 (11): 1294.
https://doi.org/10.1182/blood.V112.11.1294.1294
Published: 2008
Journal Articles

Assessment of the Economic Value of the Intercept Blood System for Platelets in Belgium.

Karen Moeremans, MD, Hans Warie, MD, Lieven Annemans, PhD, Toon Digneffe, MSc, Jacques Toté, MSc, Laurence Corash, MD
Journal: Blood
Blood (2004) 104 (11): 3156.
https://doi.org/10.1182/blood.V104.11.3156.3156
Published: 2004
Journal Articles

Bone marrow transplantation versus periodic prophylactic blood transfusion in sickle cell patients at high risk of ischemic stroke: a decision analysis

Clinical Trials & Observations
Paul J. Nietert, Miguel R. Abboud, Marc D. Silverstein, Sherron M. Jackson
Journal: Blood
Blood (2000) 95 (10): 3057–3064.
https://doi.org/10.1182/blood.V95.10.3057
Published: 2000
Journal Articles

The Costs and Cost-Effectiveness of Unrelated Donor Bone Marrow Transplantation for Chronic Phase Chronic Myelogenous Leukemia

Stephanie J. Lee, Claudio Anasetti, Karen M. Kuntz, Jonathan Patten, Joseph H. Antin, Jane C. Weeks
Journal: Blood
Blood (1998) 92 (11): 4047–4052.
https://doi.org/10.1182/blood.V92.11.4047
Published: 1998